Rationale and design of the KYOTO HEART study: effects of valsartan on morbidity and mortality in uncontrolled hypertensive patients with high risk of cardiovascular events
Rationale and design of the KYOTO HEART study: effects of valsartan on morbidity and mortality in uncontrolled hypertensive patients with high risk of cardiovascular events
复制标题
KYOTO HEART 研究的基本原理和设计:缬沙坦对心血管事件高风险未控制的高血压患者发病率和死亡率的影响
DOI:
10.1038/jhh.2008.116
复制
发表时间:
2009
影响因子:
2.7
通讯作者:
H. Matsubara
中科院分区:
文献类型:
--
作者:
T. Sawada;Tomosaburo Takahashi;Hiroyuki Yamada;B. Dahlöf;H. Matsubara
It remains to be determined whether the evidence in Western countries for blockade of the renin–angiotensin System in cardiovascular diseases could be directly applied to East Asian races including the Japanese population as a long-term strategy. The KYOTO HEART Study (KHS) is designed to investigate the add-on effect of valsartan versus conventional anti-hypertensive treatment on cardiovascular morbidity and mortality in Japanese hypertensive patients with uncontrolled blood pressure and with high cardiovascular risk. Over 3000 high-risk Japanese patients with uncontrolled hypertension were randomised to receive either additional treatment with valsartan or conventional non-angiotensin receptor blocker therapies, and the follow-up period will be at least 3 years. The primary end point is a composite of defined cardio-or cerebro-vascular events. Secondary end points include all causes of mortality, worsening of cardiac function, new onset or worsening of arrhythmias or diabetes mellitus. The KHS will provide new evidence for the management of blood pressure in hypertensive patients with high risk.
DOI:
--
发表时间:
2005
期刊:
Diabetes Care 28
影响因子:
--
作者:
Miura Y;Yamamoto N;Tsunekawa S;Taguchi S;Eguchi Y;Ozaki N;Oiso Y
通讯作者:
Oiso Y
影响因子:
168.9
作者:
Mochizuki, Seibu;Dahloef, Bjorn;Tajima, Naoko
通讯作者:
Tajima, Naoko